Orbis Allan Gray LTD Teva Pharmaceutical Industries LTD Transaction History

Orbis Allan Gray LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$15.58 - $20.01 $77 Million - $98.9 Million	-4,942,091 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$14.59 - $23.84 $41.6 Million - $68 Million	2,850,488 Added 136.28%	4,942,091 $76.2 Million
Q3 2018 Nov 14, 2018	BUY	$21.06 - $25.65 $44 Million - $53.6 Million	2,091,603 New	2,091,603 $45.1 Million

625

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $25.3B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Orbis Allan Gray LTD, based on Form 13F filings with the SEC.

Stay updated on Orbis Allan Gray LTD with notifications on news.